Home/Filings/4/0001213900-19-020111
4//SEC Filing

Bartushak Jaime 4

Accession 0001213900-19-020111

CIK 0001506251other

Filed

Oct 9, 8:00 PM ET

Accepted

Oct 10, 4:06 PM ET

Size

11.1 KB

Accession

0001213900-19-020111

Insider Transaction Report

Form 4
Period: 2019-10-08
Bartushak Jaime
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Purchase Common Stock)

    2019-10-08+100,000100,000 total
    Exercise: $0.67Exp: 2029-10-08Common Stock (100,000 underlying)
Holdings
  • Stock Option (Right to Purchase Common Stock)

    Exercise: $10.50Exp: 2026-07-06Common Stock (48,267 underlying)
    48,267
  • Common Stock

    60,353
  • Stock Option (Right to Purchase Common Stock)

    Exercise: $1.62Exp: 2028-09-04Common Stock (70,000 underlying)
    70,000
  • Stock Option (Right to Purchase Common Stock)

    Exercise: $3.45Exp: 2027-09-15Common Stock (25,000 underlying)
    25,000
Footnotes (4)
  • [F1]The options were granted on October 8, 2019. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
  • [F2]One-third of the shares of the Company's common stock underlying the grant vest on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, September 4, 2018, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
  • [F3]On September 15, 2017 the Reporting Person was granted a ten-year option to purchase 25,000 shares of common stock at an exercise price of $3.45 per share. The options vest as follows: 8,333 shares vest on September 13, 2018, and then 694 shares per month for the next 24 months.
  • [F4]On July 6, 2016 the Reporting Person was granted a ten-year option to purchase 48,267 shares of common stock at an exercise price of $10.50 per share. The options vest as follows: 16,089 shares vest on July 7, 2017, and then 1,341 shares per month for the next 24 months.

Documents

1 file

Issuer

Citius Pharmaceuticals, Inc.

CIK 0001506251

Entity typeother

Related Parties

1
  • filerCIK 0001725077

Filing Metadata

Form type
4
Filed
Oct 9, 8:00 PM ET
Accepted
Oct 10, 4:06 PM ET
Size
11.1 KB